Niranib 100mg Capsules

Generic Name: Not Available

Out of stock
Regular price Rs.100,000.00 PKR inc. VAT

You can promote by sharing on social networks on the links.

Product Description

Product Name: Niranib 100mg Capsules

Product Form: Capsules

Pack Size: 30's

Manufactured By: Everest Pharmaceuticals

Used For:

  • Cancer Treatment: Niranib is used in the treatment of certain types of cancers, particularly those that are associated with aberrant signaling pathways. It may be prescribed for conditions like advanced breast cancer, specifically hormone receptor-positive breast cancer, or other malignancies as determined by a healthcare provider.

Side Effects:

  • Gastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain are common.
  • Fatigue: Many patients experience tiredness or weakness.
  • Rash: Skin rashes, including acneiform rash or dry skin.
  • Appetite Changes: Reduced appetite leading to weight loss.
  • Liver Toxicity: Elevation of liver enzymes or liver dysfunction may occur.
  • Heart Issues: Potential for cardiovascular side effects, including hypertension (high blood pressure).
  • Blood Disorders: Can affect blood cell counts, leading to anemia, neutropenia (low white blood cells), or thrombocytopenia (low platelet count).

Precautions:

  • Liver Function: Regular monitoring of liver function is required due to the risk of hepatotoxicity.
  • Cardiovascular Monitoring: Patients should have their blood pressure and heart health monitored, especially if they have pre-existing conditions.
  • Drug Interactions: Inform your healthcare provider of all medications and supplements you are taking, as Niranib can interact with other drugs.
  • Pregnancy and Breastfeeding: Not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant.
  • Pre-existing Conditions: Patients with a history of certain health conditions should discuss their medical history with their healthcare provider to ensure Niranib is appropriate for them.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)